- About ERC
- Projects & figures
- News & Events
- Managing your project
According to the World Health Organisation (WHO), more than 1.9 billion adults were overweight in 2016. Of these, over 650 million were obese and therefore at a higher risk of developing cardiovascular diseases, diabetes, musculoskeletal disorders and some forms of cancers. In one of the largest studies of its kind, researchers have looked into the reasons why some people are more likely to gain weight while others manage to stay thin.
A microchip device to detect tumour cells in the blood, at a glance
There are trillions of cells in the human body of different sizes and shapes. In such a densely populated environment, the chances of detecting a single tumour cell circulating in the bloodstream, seem pretty weak. Yet, to prevent potential metastasis, responsible for 90% of cancer-related deaths, early detection is a must. Liesbet Lagae, an engineer based at Imec in Leuven, Belgium, is developing a microchip device that hunts, inspects and sorts out malignant cells circulating in the blood, sharply and cheaply.
Alina Badescu is a young researcher, with her head in the sky and her thoughts firmly buried under layers of rock – in some of her native Romania’s most stunning salt mines. Her work focuses on neutrinos, small subatomic particles that can tell us a lot about the phenomena in the universe: the birth of stars, the explosion of supernovas, black holes.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.
Sino alla metà del XV secolo, i libri venivano scritti a mano. Nel 1455 venne stampata la Bibbia di Gutenberg, cambiando per sempre la società. Negli anni successivi milioni di libri furono stampati in tutta Europa. Cosa si sa oggi di questi libri? Chi li leggeva? Chi li acquistava? Chi li annotava? Cristina Dondi è una ricercatrice dell'Università di Oxford e curatrice della mostra "Printing Revolution 1450-1500. I 50 anni che hanno cambiato l'Europa" aperta al Museo Correr di Venezia lo scorso settembre. Forte del successo ottenuto, con oltre 90 000 visitatori a dicembre 2018, la mostra è stata prolungata sino al 30 aprile 2019. Un percorso di scoperta attraverso libri antichi e moderni strumenti digitali, frutto di anni di rigorose ricerche finanziate dall'ERC, il Consiglio europeo delle Ricerche. Sentiamo in questa intervista come nasce la passione di Cristina Dondi per i primi libri a stampa e cosa ha scoperto con le sue ultime ricerche che l'hanno portata a collaborare con biblioteche di tutto il mondo.
Until the middle of the 15th century, books were copied by hand. After the printing of the Gutenberg Bible, in Mainz, printed books started to circulate in Europe marking the start of a new era. But what do we know about the first modern books? What were they about? Who wrote them, bought them, read them? Prof. Cristina Dondi is chasing these answers, following the breadcrumbs left by these incredible volumes.
Matchmaking science ready for release on the market with investors in start-ups is the aim of Y Science 2018, the official side event to the world-renowned Slush. Techy events like these may seem almost science fictional at moments and it can be easy to forget that many of the ideas being pitched on stage began with really basic science.
The increasing development of wearable technology sparks the need for new, innovative ways to interact with our shiny gadgets. Deviating from the conventional approach based on touch-sensitive devices, Prof. Jürgen Steimle aims at producing body-worn user interfaces that can be applied directly on the skin. Highly personalised, biocompatible and ultrathin, these devices will seamlessly blend with the human skin to create a technological extension of our body.
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
A project funded by the ERC developed an innovative and comprehensive framework to study energy poverty in Europe. It also produced evidence applicable beyond academia, laying ground for the EU’s Energy Poverty Observatory set up in 2018.